Rani Therapeutics Holdings (RANI) Competitor Comparison
We are evaluating the key criteria listed to compare Rani Therapeutics Holdings (RANI) against its competitors in the Biotechnology industry.
Market Capitalization
234 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
165 / 337Free Cashflow
165 / 352Quick Ratio
109 / 357Earnings per Share
142 / 359Dividend yield
0 / 6Total Cash
248 / 358Performance 3 years
313 / 368Performance 5 years
231 / 368Performance 10 years
202 / 368Linearity 3 years
299 / 368Linearity 5 years
158 / 368Linearity 10 years
130 / 368Total Rank
242 / 368Dividend Rank
254 / 368Valuation Rank
122 / 368Piotroski Rank
40 / 368Muliplier Rank
29 / 368Total Revenue - RANI ranking 0 / 300
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.